Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net increase in net assets from operations $ 1,399,381 $ 2,170,277
Adjustments to reconcile net increase in net assets to net cash used in operating activities:    
Investments in portfolio companies (10,837,878) (5,570,000)
Proceeds from sale of portfolio investments 3,503,186 268,329
Proceeds from loan repayments 2,581,906 300,000
Net realized gain on sales and dispositions of portfolio investments (3,450,092) (53,388)
Change in unrealized depreciation (appreciation) on investments 2,890,296 (1,401,973)
Deferred income tax benefit (26,636) (5,535)
Amortization 6,250 6,250
Original issue discount amortization (7,002) (7,752)
Non-cash conversion of debenture interest (328,829) (216,286)
Changes in operating assets and liabilities:    
Increase in interest receivable (103,155) (1,154)
Increase in other assets (70,797) (2,863)
(Increase) decrease in prepaid income taxes (26,535) 32,457
Increase in accounts payable and accrued expenses 126,570 30,980
Decrease in due to investment adviser (676,817) (316,453)
Increase in capital gains incentive fees payable 112,300 291,000
Increase in deferred revenue 66,969 64,481
Total adjustments (6,240,264) (6,581,907)
Net cash used in operating activities (4,840,883) (4,411,630)
Cash flows from financing activities:    
Net proceeds from line of credit 2,950,000 5,400,000
Payment of cash dividend (645,255) (516,204)
Net cash provided by financing activities 2,304,745 4,883,796
Net (decrease) increase in cash (2,536,138) 472,166
Cash:    
Beginning of period 3,295,321 1,368,996
End of period $ 759,183 $ 1,841,162